Takeda Pharmaceutical Co Ltd

Q3 2024 13F Holdings Report, Stock Holdings

Signature - Title
Amit Singh - Senior Vice President and Head of Treasury
Location
Tokyo, Japan
Holdings as of
September 30, 2024
Value $
$38M
Num holdings
10
Date filed
2/13/2025, 06:40 AM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included HLVX, WVE, OVID, STTK, and EQ.
Previous filing
Q2 2024 - Feb 13, 2025
Next filing
Q4 2024 - Feb 12, 2025
SEC
View on sec.gov
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2024 Q3 compared to 2024 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Amit Singh Senior Vice President and Head of Treasury Tokyo, Japan 2/13/2025

Other Included Managers (1):

Num Name Location File Number
1 Takeda Vaccines, Inc. Cambridge, MA 028-24939